AU8278498A - Combination drug therapies comprising aminoglycoside antibiotics and n,n'-disubstituted guanidines - Google Patents
Combination drug therapies comprising aminoglycoside antibiotics and n,n'-disubstituted guanidinesInfo
- Publication number
- AU8278498A AU8278498A AU82784/98A AU8278498A AU8278498A AU 8278498 A AU8278498 A AU 8278498A AU 82784/98 A AU82784/98 A AU 82784/98A AU 8278498 A AU8278498 A AU 8278498A AU 8278498 A AU8278498 A AU 8278498A
- Authority
- AU
- Australia
- Prior art keywords
- combination drug
- drug therapies
- aminoglycoside antibiotics
- disubstituted guanidines
- guanidines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5186097P | 1997-07-07 | 1997-07-07 | |
| US60051860 | 1997-07-07 | ||
| PCT/US1998/013640 WO1999002145A1 (en) | 1997-07-07 | 1998-07-06 | Combination drug therapies comprising aminoglycoside antibiotics and n,n'-disubstituted guanidines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU8278498A true AU8278498A (en) | 1999-02-08 |
Family
ID=21973809
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU82784/98A Abandoned AU8278498A (en) | 1997-07-07 | 1998-07-06 | Combination drug therapies comprising aminoglycoside antibiotics and n,n'-disubstituted guanidines |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU8278498A (en) |
| WO (1) | WO1999002145A1 (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0022922D0 (en) * | 2000-09-19 | 2000-11-01 | Chapman Robert E | Compounds for use in medicine |
| US20050085432A1 (en) * | 2001-12-26 | 2005-04-21 | Aviva Lapidot | Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections |
| US7345018B2 (en) | 2002-04-25 | 2008-03-18 | Reception Aps | Method of treating side effects induced by therapeutic agents |
| WO2004084876A2 (en) * | 2003-03-26 | 2004-10-07 | Recepticon Aps | Use of compounds for the prevention of drug-induced cell toxicity |
| GB0315671D0 (en) | 2003-07-04 | 2003-08-13 | Chelsea And Westminster Nhs Tr | Improvements in or relating to organic compounds |
| US20100222316A1 (en) | 2004-04-29 | 2010-09-02 | Abbott Laboratories | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| US8415354B2 (en) | 2004-04-29 | 2013-04-09 | Abbott Laboratories | Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| US7880001B2 (en) | 2004-04-29 | 2011-02-01 | Abbott Laboratories | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme |
| EP1846363B1 (en) | 2005-01-05 | 2012-04-25 | Abbott Laboratories | Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| US8198331B2 (en) | 2005-01-05 | 2012-06-12 | Abbott Laboratories | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| EP1846362A2 (en) | 2005-01-05 | 2007-10-24 | Abbott Laboratories | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| US20090192198A1 (en) | 2005-01-05 | 2009-07-30 | Abbott Laboratories | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| JP5736098B2 (en) | 2007-08-21 | 2015-06-17 | アッヴィ・インコーポレイテッド | Pharmaceutical composition for treating central nervous system disorders |
| WO2010048164A2 (en) * | 2008-10-20 | 2010-04-29 | University Of South Florida | N,n'-di-p-bromophenyl guanidine treatment for stroke at delayed timepoints |
| GB201008047D0 (en) | 2010-05-14 | 2010-06-30 | Ge Healthcare Ltd | Method of synthesis |
| WO2016121862A1 (en) * | 2015-01-28 | 2016-08-04 | 国立大学法人九州大学 | Anti-inflammatory drug and uses thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5221693A (en) * | 1990-08-24 | 1993-06-22 | The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services | Antimicrobial and antiviral bis-adamantanamine compounds |
| WO1992014697A1 (en) * | 1991-02-08 | 1992-09-03 | Cambridge Neuroscience, Inc. | Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers |
-
1998
- 1998-07-06 WO PCT/US1998/013640 patent/WO1999002145A1/en active Application Filing
- 1998-07-06 AU AU82784/98A patent/AU8278498A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999002145A1 (en) | 1999-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU4818099A (en) | Phosphodiesterase-v modulator drugs and their uses | |
| AU1719800A (en) | Drug delivery systems and methods | |
| AU6876498A (en) | Intravesical drug delivery system | |
| AU7796198A (en) | Novel acoustically active drug delivery systems | |
| AU3204995A (en) | Closed drug delivery system | |
| HUP0103793A3 (en) | N-(2-aryl-propionyl)-sulfonamids, their use and pharmaceutical preparations containing them | |
| AU8278498A (en) | Combination drug therapies comprising aminoglycoside antibiotics and n,n'-disubstituted guanidines | |
| AU6140598A (en) | Multipathway electronically-controlled drug delivery system | |
| AU6982598A (en) | Cassette and delivery system | |
| AU1939997A (en) | Nitrogenous tricyclic compounds and drugs comprising the same | |
| AU1716999A (en) | Secure class resolution, loading and definition | |
| AU3813499A (en) | The use of dihydropyrimidines as medicaments, and novel substances | |
| AU3460297A (en) | Taxane derivatives and drugs containing the same | |
| IL134293A0 (en) | Linear peptides derived from antibiotic peptides, preparation and use for vectoring active substances | |
| AU5387898A (en) | Pharmaceutical agents | |
| AU2415299A (en) | Substituted benzenesulfonamide derivatives and their pharmaceutical use | |
| AU7711098A (en) | Drug delivery system | |
| AU2543399A (en) | Anticonvulsant drugs and pharmaceutical compositions thereof | |
| AU7201998A (en) | Drug delivery system | |
| AU7454698A (en) | Improvement in medicament administration system | |
| AU7095296A (en) | Phosphorylamides, their preparation and use | |
| AU3866897A (en) | Diamide compounds and drugs containing the same | |
| AU4874997A (en) | Nitric oxide donor drugs | |
| AU6119398A (en) | Phenylpropenone compounds and medicines containing the same | |
| AU4636396A (en) | Antiglucocorticoid medicament |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |